FibriTimer

In the heart of India’s bustling healthcare industry, where 80% of medical devices are imported and operational costs are skyrocketing for small to mid-size labs, innovation was long overdue. Enter FibriTimer Zeta-1, the trailblazing semi-automated coagulation analyzer that is transforming diagnostics in India.

Developed by Dfine Bioinnovations Pvt Ltd, FibriTimer Zeta-1 is India’s first indigenous coagulation analyzer that combines affordability, precision, and innovation, addressing critical gaps in healthcare diagnostics. Built with patented dual technology that integrates optical and mechanical methods, this device delivers fast and accurate results for vital tests such as PT/APTT, Fibrogen, Lupus, and D-dimer.

The Problem We’re Solving

Small to mid-size labs across India have struggled to afford imported coagulation analyzers, resulting in outsourcing critical tests. This delays patient treatment and compromises healthcare outcomes. To compound the issue, reagent wastage and high consumable costs often burden these labs, reducing their profitability and efficiency.

Recognizing these challenges, Dfine Bioinnovations took on the mission to create a cost-effective, efficient, and indigenous solution that caters specifically to small and mid-sized labs.

FibriTimer Zeta-1: Redefining Affordability and Efficiency

At its core, FibriTimer Zeta-1 is designed to address the pressing need for accessible and reliable coagulation testing. Here’s why it stands out:

• Patented Dual Technology: Provides unparalleled precision and flexibility, allowing critical sample verification with confidence.
• Cost-Effective Solution: 20-30% more affordable than imported alternatives, drastically reducing operational expenses.
• User-Friendly Design & Features: Features an intuitive touchscreen interface, ensuring ease of use for lab technicians.
• Built-In Power Backup: Offers uninterrupted performance with a built-in UPS, a crucial advantage for labs in areas with frequent power outages.

Experts behind development of Device:

Choosing the right Haemostasis system is crucial for any lab, as it directly impacts diagnostic accuracy and patient outcomes. Recognizing the market gaps and the need for affordable, high-quality solutions, a team of experts with over 50 years of combined experience in IVD devices and specialization in coagulation analysis came together. Over the last three years, their relentless dedication and expertise have culminated in the phenomenal FibriTimer Zeta-1. This device ensures unmatched performance, delivering precise and reliable results at an economical price point, perfectly tailored to meet the needs of small to mid-size labs.

Proven Performance

The FibriTimer Zeta-1 has undergone extensive internal and external validation, firmly establishing its precision and reliability in the diagnostic landscape. Its stellar performance outcomes have even been published in the prestigious International Journal of Health Technology and Innovation, cementing its reputation as a trusted diagnostic tool. Validation studies conducted at renowned institutions like Specialist Hospital, Quantum Diagnostics in Vizag, Trustwell Hospital, and Manipal Hospital in Bangalore further attest to its reliability and quality. The FibriTimer Zeta-1 is setting new benchmarks in the field of coagulation analysis, providing labs with an unparalleled combination of performance and affordability.

FibriTimer Zeta-1 Vs Other Available options in Indian Market:

The FibriTimer Zeta-1 stands out as a groundbreaking coagulation analyzer, tailored specifically for small to mid-size labs in India. Unlike other imported options, it is indigenously developed and incorporates patented dual technology, ensuring precise and efficient results while being cost-effective. The device offers unique features like a user-friendly touchscreen, built-in power backup, and small reagent packs to minimize operational costs and wastage. Refer to the table below for a detailed comparison.

“Dual Technology” a great value addition:

Dual enhances lab efficiency by offering flexibility in result verification, especially for difficult samples. It boosts reporting confidence, expands test options on a single platform, and empowers small to mid-size labs by eliminating the need for multiple instruments for different tests and avoiding outsourcing. This leads to cost reduction and faster, more efficient reporting for timely patient treatment. Company has secured Indian Patent(Patent no: 529922) for Dual technology.

Designed for India, Built for the World

FibriTimer Zeta-1 embodies the spirit of “Make in India” by offering a local solution to global problems. With its affordable pricing and cutting-edge technology, this device empowers labs to deliver faster, more accurate test results, especially in rural and underserved areas. Beyond India, Dfine Bioinnovations plans to take this innovation global, ensuring access to efficient healthcare diagnostics worldwide and Operon Biotech & Healthcare has joint hands as marketing partner.

Transforming Lives, One Test at a Time

FibriTimer Zeta-1 is more than just a product; it’s a movement towards self-reliance in the healthcare industry. By equipping small and mid-size labs with this groundbreaking analyzer, we’re not only improving diagnostic efficiency but also fostering timely, life-saving treatments.

What Next:

Our R&D team is tirelessly pushing the boundaries of innovation to support diagnostics with cutting-edge, yet cost-effective solutions. Building on the success of Zeta-1, we are gearing up to launch Zeta-2, a two-channel semi-automatic coagulation analyzer designed to enhance efficiency and throughput for small to mid-size labs. Beyond this, we are exploring advanced automation and Point-of-Care Testing (POCT) solutions to offer a comprehensive range of diagnostic tools. These upcoming products underscore our commitment to revolutionizing healthcare with indigenous, affordable, and efficient innovations. Stay tuned for the next wave of transformative diagnostic technologies!

 Join the Revolution

As FibriTimer Zeta-1 rolls out across India, the journey to transform diagnostics has just begun. With plans to scale globally and introduce advanced versions, Dfine Bioinnovations is poised to shape the future of healthcare diagnostics.